Company news
Viking Therapeutics, Inc. news in 2022
Viking Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
Viking Therapeutics to Present at Stifel 2022 Healthcare Conference
November 7, 2022
Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
October 25, 2022
Viking Therapeutics to Report Financial Results for Third Quarter 2022 on October 26, 2022
October 17, 2022
Viking Therapeutics to Participate in Fireside Chat at BTIG Biotechnology Conference 2022
August 1, 2022
Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
July 26, 2022
Viking Therapeutics to Report Financial Results for Second Quarter 2022 on July 27, 2022
July 19, 2022
Viking Therapeutics Announces FDA Has Lifted Clinical Hold on Phase 1b Trial of VK0214 in Patients with X-ALD
July 18, 2022
Viking Therapeutics to Present at William Blair Biotech Focus Conference 2022
July 5, 2022
Viking Therapeutics to Present at H.C. Wainwright Global Investment Conference
May 15, 2022
Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
April 26, 2022
Viking Therapeutics to Report Financial Results for First Quarter 2022 on April 27, 2022
April 19, 2022
Viking Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
April 5, 2022
Viking Therapeutics to Present at Upcoming Investor Conferences
March 7, 2022
Viking Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
February 8, 2022
Viking Therapeutics to Present at SVB Leerink 11th Annual Global Healthcare Conference
February 6, 2022
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2021 on February 9, 2022
February 1, 2022
Viking Therapeutics Announces Clinical Hold on Phase 1b Trial of VK0214 in Patients with X-ALD
January 23, 2022
Viking Therapeutics Announces Initiation of Phase 1 Clinical Trial of VK2735, Company's Lead Dual GLP-1/GIP Receptor Agonist
January 9, 2022
Viking Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference
January 2, 2022